Cargando…
Donor Derived Cell Free DNA in Kidney Transplantation: The Circa 2020–2021 Update
The routine surveillance of kidney transplant allografts has relied on imperfect non-invasive biomarkers such as creatinine and urinary indices, while the gold standard allograft biopsy is associated with risk of bleeding, organ injury and sampling errors. Donor derived cell free DNA (dd-cfDNA) is b...
Autores principales: | Kant, Sam, Brennan, Daniel C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198901/ https://www.ncbi.nlm.nih.gov/pubmed/35721467 http://dx.doi.org/10.3389/ti.2022.10448 |
Ejemplares similares
-
Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy—Results of a Prospective Single-Center Trial
por: Benning, Louise, et al.
Publicado: (2023) -
Assessment of Donor Derived Cell Free DNA (dd-cfDNA) at Surveillance and at Clinical Suspicion of Acute Rejection in Renal Transplantation
por: Mantios, Evangelos, et al.
Publicado: (2023) -
Absolute Quantification of Donor-Derived Cell-Free DNA in Pediatric and Adult Patients After Heart Transplantation: A Prospective Study
por: Böhmer, Jens, et al.
Publicado: (2023) -
Deceased Donor Characteristics and Kidney Transplant Outcomes
por: Sharif, Adnan
Publicado: (2022) -
Recoverability of Diabetic Nephropathy of Donor Kidney After Kidney Transplantation
por: Lee, Kyo Won, et al.
Publicado: (2022)